CollabRx (@collabrx) header
CollabRx (@collabrx) profile picture

We provide solutions for evidence-based therapy selection in genomic medicine and #PrecisionOncology. Tweet us your comments about #Cancer #MentalHealth

San Francisco, CA
Joined October 2008
Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)Photo by CollabRx (@collabrx)
January is #CervicalCancer Awareness Month! Cervical #cancer usually doesn't have symptoms, so it's critical to get screened regularly. bit.ly/2hWRty2
4
78
13
39
In case you missed last night's #BCSM year end wrap up: bcsm.org/bcsm-2017-wrap/
There are different types of treatment for patients with #cervicalcancer. An overview: cancer.gov/types/cervical/pa… #cervicalhealthmonth
Did you know more than 90% of cervical cancers today are caused by infection with the human papillomavirus (#HPV)? RT and learn more about the risk factors for #cervicalcancer: bit.ly/2F0cvVX
1
11
3
16
histoCAT software for visualization and quantitative analysis of highly multiplexed imaging data. bit.ly/2hHdZgn #imagingdata
Earlier today, my colleague @SGottliebFDA & I discussed how @theNCI & @US_FDA can find better ways to work together to make faster progress against cancer.
6
32
4
93
How about that? Precision Radiation Oncology. xitter.gq/collabrx/status/942771…
The prediction of #tumor sensitivity to radiation would be a powerful tool for precision #radiationoncology. #RadOnc #genomics #biomarkers #cancer @UABCancerCenter collabrx.com/accuracy-precis…
1
1
#2018NCIRetreat is a great opportunity for intramural researchers @NCIEpiTraining @NCIResearchCtr to discuss the results of their unique research & the future of #cancerresearch with fellow @theNCI investigators. I was pleased to join the conversation. xitter.gq/NCIResearchCtr/status/…
3
17
CollabRx retweeted
Open comment for draft guideline on adjuvant chemotherapy and targeted therapy for breast cancer runs through Jan. 24. Submit feedback: bit.ly/2y7AQEM CC @mdmanishshah @ndenduluri1
Thanks to screenings, cervical cancer is rare in the U.S. compared to other cancers. Visit @theNCI for more info on screenings: bit.ly/2AABC2c #CervicalHealthMonth
New year, new cancer treatments to test. If you or someone you love has squamous cell #lungcancer, learn more about the @LungMAP precision medicine trial backed by @SWOG @theNCI @FNIH_Org and @CancerResrch Visit the website at lung-map.org #LCSM
2
3
CollabRx retweeted
Clinical Trials Abstract and Late-breaking Abstract Submission Deadline: Jan. 23 for the 2018 AACR Annual Meeting. sm.aacr.org/N9jk30hG2kH #AACR18
Delighted to speak with members of the Deadliest Cancers Coalition today. We covered a lot of ground, from basic science to cancer care, and I look forward to more discussion.
7
3
38
RT Transplant_Doc "RT NEJM: In patients with untreated EGFR-mutated #lungcancer, osimertinib is superior to erlotinib & gefitinib and has fewer serious adverse events. Full study: nej.md/2AMzkJN https://xitter.gq/t.co/3eRaF5uWVj"
1
1
Check Out NYU Langone Health 's Perlmutter Cancer Center Website. Made for Patients and Their Families. lnkd.in/eP2-AHS
Hmm...seems like a safe bet!! xitter.gq/aacr/status/9500758341…
On the #blog: AACR President-Elect Dr. Elizabeth Jaffee predicts that this year we will see approval of anti-PD1/PDL1 and anti-CTLA4 antibody therapeutics sm.aacr.org/YMrt30hBH7v #2018
3
4
Patient had #melanoma on arm: Breslow depth 4.5 mm, 7 mitoses/mm3, ulceration present. Here is the axillary sentinel lymph node on MART-1 immunostain. Your diagnosis? #mysterydiagnosis #mysteryDxMondays #sanjayed #dermpath #Pathology #dermatology @smlungpathguy
12
40
1
62